Browse Category

Market News News 25 October 2025 - 2 November 2025

Pfizer Stock Surges on Trump Deal & Obesity Drug Drama – Is a Comeback Coming?

Pfizer Stock Surges on Trump Deal & Obesity Drug Drama – Is a Comeback Coming?

Company Background & Significance Founded in 1849, Pfizer Inc. has grown into a pillar of the pharmaceutical industry, known for landmark drugs and vaccines. From breakthrough treatments like Lipitor (cholesterol) and Viagra (ED), to its 2020 partnership with BioNTech delivering the first approved COVID-19 vaccine, Pfizer’s innovations have had global impact. Today the company employs about 81,000 people worldwide and…
Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Company Overview: Oil Logistics and Remediation at Vivakor Vivakor, Inc. is a micro-cap energy infrastructure and environmental services company based in Dallas, Texas. The firm specializes in crude oil transportation, storage, and waste remediation. Its operations include a fleet of trucks for hauling crude oil and produced water, crude storage terminals, and even a proprietary pipeline (the Omega Gathering Pipeline)…
Perimeter Solutions (PRM) Stock Soars on Earnings Beat and New Firefighting Deal

Perimeter Solutions (PRM) Stock Soars on Earnings Beat and New Firefighting Deal

Company Overview: A Niche Fire Safety Leader with Specialty Chemical Roots Perimeter Solutions, based in Clayton, Missouri, is a specialty chemicals company focused on fire safety products and related services, alongside a smaller specialty chemicals segment Thedelawarepost Thedelawarepost. Founded in 1963, the company is best known for manufacturing and distributing firefighting retardants (like its PHOS-CHEK® fire retardant) and providing equipment/support…
Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Mixed Third-Quarter Financial Results Baxter’s Q3 showed a mixed picture. Revenue from continuing operations rose about 5% year-over-year to $2.84 billion, helped by strong performance in its Pharmaceuticals and Healthcare Systems units Baxter Baxter. However, sales fell short of the street’s ~$2.88 billion estimate Reuters. On profit, Baxter earned an adjusted $0.69 per share, well above the ~$0.60 expected Reuters Chartmill. (GAAP…
NYSE Skyrockets to Record Highs as AI Frenzy, Fed Rate Cut Bets Fuel Stock Surge

NYSE Skyrockets to Record Highs as AI Frenzy, Fed Rate Cut Bets Fuel Stock Surge

Wall Street Hits New Highs as Rally Accelerates Stocks extended their winning streak into mid-week, with the New York Stock Exchange (NYSE) seeing across-the-board gains. On Tuesday, the Dow rose 0.34%, the S&P 500 0.23%, and the Nasdaq 0.80% – all closing at record peaks ts2.tech. This adds to a robust multi-day run: U.S. indexes have advanced in eight of…
Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound?

Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound?

Milestone News: Manufacturing Boost and European Deals Profusa’s after-hours surge came on the heels of a positive company update. The California-based digital health firm announced it has completed key manufacturing initiatives, creating enough production capacity to supply more than twice the units needed to meet its 2026 revenue goals for the Lumee™ continuous oxygen sensor system Benzinga. Fred Knechtel, Profusa’s…
Lucid Group (LCID) October 7 2025 Stock Analysis: Gravity SUV Lifts Deliveries to Record High – Will Expiring Tax Credits Stall the Momentum?

Lucid Motors (LCID) Stock Soars on Record EV Deliveries and Saudi Backing – Analysts Split on 2026 Outlook

The Road Ahead for Lucid (Q4 2025 – 2026) Looking forward, Lucid’s Q4 execution and 2026 outlook will be critical. The company must prove it can convert its growing order book – including the Saudi government fleet orders and Uber robotaxi deal – into scalable production without draining its ~$4–5 billion cash reserve. Interim CEO Winterhoff has emphasized “aggressively reducing costs”…
YPF Stock Soars on LNG Mega-Deal and Milei’s Reforms – Will Argentina’s Oil Giant Keep Climbing?

YPF Stock Soars on LNG Mega-Deal and Milei’s Reforms – Will Argentina’s Oil Giant Keep Climbing?

Recent News & Developments Milei’s Market-Friendly Agenda: Since taking office in December 2023, President Javier Milei has pursued aggressive free-market reforms that directly impact YPF and the energy sector. Early on, Milei floated plans to privatize YPF, igniting a buying frenzy in YPF’s stock Reuters. “YPF was one of several state-controlled companies he plans to sell,” Milei declared after his…
Google’s $3B AI Bet Skyrockets TeraWulf (WULF) Stock – Latest News & Analysis

TeraWulf Stock Skyrockets 100% on Google’s $3B AI Bet – But One New Warning Looms

TeraWulf, a Bitcoin miner with green energy infrastructure, is expanding into AI-focused data centers – a strategy that has attracted backing from Google in 2025 ts2.tech ts2.tech. TeraWulf’s High-Flying 2025 Rally TeraWulf Inc. (NASDAQ: WULF) has been one of 2025’s standout stock market stories. The company’s share price has surged over 100% since January ts2.tech, vastly outperforming broader market indices.…
DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

Datavault AI (DVLT) Stock Skyrockets 52% on $150M Bitcoin Deal and Major Partnerships

DVLT Stock Price and Volume Surge Datavault AI’s Nasdaq-traded shares closed at $3.42 on Oct. 24, 2025, after leaping 52% that day ts2.tech. In mid-day trading the price briefly hit $3.49 – a new 52-week high – before settling. This represented a sharp jump from the prior close around $2.25. Trading volume on Oct. 24 was extraordinary: about 192–197 million…
1 57 58 59 60 61 63

Stock Market Today

  • Abbott Laboratories (ABT.SW) Trades at CHF100 Ahead of Jan 22 Earnings
    January 19, 2026, 9:27 AM EST. ABT.SW stock trades at CHF100.00 on the SIX market on Jan 19, 2026, ahead of Abbott Laboratories' earnings report due Jan 22. The shares carry a price-to-earnings (PE) ratio of 15.82, below the healthcare sector average of 33.73, signaling potential undervaluation. Key catalysts include diagnostic volume and medical devices sales, which investors will watch for guidance. Forecasts project a 10.78% quarterly upside but an 8.31% yearly downside, reflecting mixed expectations amid stable cash flow and modest growth. Meyka AI assigns a BUY rating with a B+ grade, noting technical indicators near the 50-day moving average and light volume. Risks include normalization of diagnostic demand and regulatory pressures; opportunities hinge on growth acceleration. Earnings-driven volatility expected on release day.
Go toTop